02137.HK 股价走势图
BRII-B (02137.HK)
Brii Biosciences Limited
HK$1.34
0%
$0
休市： May 08, 16:00:00 HKT
返回
Brii Biosciences Limited (02137.HK)
关键数据
前收盘价
$1.38
开盘价
$1.34
当日区间
$1.34 - $1.36
52周范围
$1.28 - $2.54
交易量
309.5K
平均成交量
1.2M
股息收益率
--
每股收益（TTM）
-0.59
市值
$965.8M
什么是 BRII-B？
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The company is headquartered in Beijing, Beijing and currently employs 96 full-time employees. The company went IPO on 2021-07-13. The firm's main products include BRII-179, a candidate drug for hepatitis B virus (HBV) immunotherapy, Tobevibart, an investigational neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg), as well as soralimixin (BRII-693), a synthetic lipopeptide for treating multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections. The firm primarily operates its businesses in the domestic market.
